Verily
{{short description|Life sciences research organization}}
{{Use mdy dates|date=August 2023}}
{{Infobox company
| name = Verily Life Sciences LLC
| logo = Verily Life Sciences.svg
| image = Verily Life Sciences.jpg
| image_caption = Former headquarters in South San Francisco, California
| type = Subsidiary
| key_people = Stephen Gillett (CEO)
| industry = {{plainlist|
}}
| owner = Google Inc. (until 2015)
Alphabet Inc. (2015–present)
| parent = Alphabet Inc.
| subsid = Lift Labs
| homepage = {{URL|https://verily.com}}
| foundation = {{start date and age|2015|12|7}}
| hq_location = Dallas, Texas
| former_name = Google Life Sciences
| revenue = US$559 million (2022)
| operating_income = −US$568 million (2022)
| num_employees = {{circa|1,100}} (2023)
}}
Verily Life Sciences LLC,{{Cite web |date=2015-08-03 |title=Verily Life Sciences LLC |url=https://opencorporates.com/companies/us_de/5794874 |access-date=2023-08-19 |website=OpenCorporates}} also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences.{{cite web|url=http://www.nih.gov/about/director/09152015_statement_insel.htm |title=NIH Director?s Statement Regarding Dr. Thomas Insel?s Departure - the NIH Director - National Institutes of Health (NIH) |access-date=September 15, 2015 |url-status=dead |archive-url=https://web.archive.org/web/20150918002515/http://www.nih.gov/about/director/09152015_statement_insel.htm |archive-date=September 18, 2015 }}{{cite news|last1=Carey|first1=Benedict|title=Head of Mental Health Institute Leaving for Google Life Sciences|url=https://www.nytimes.com/2015/09/16/health/tom-insel-national-institute-of-mental-health-resign.html|newspaper=New York Times|date=September 15, 2015 }} The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc.{{cite web|last1=Brin|first1=Sergey|title=Google+ Post|url=https://plus.google.com/+SergeyBrin/posts/WAhzzFAzh3f}} with restructuring completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily.{{Cite web|title = Google Life Sciences debuts a new name, Verily|url = http://www.statnews.com/2015/12/07/verily-google-life-sciences-name/|website = STAT| date=December 7, 2015 |access-date = 2015-12-07}}{{Cite web|url=https://www.youtube.com/watch?v=Lyv0_GIGSbY|title=Introducing Verily|date=December 7, 2015|website=YouTube|access-date=December 24, 2017}} As of 2025, Verily is the first “bet” to successfully divest from Google and is now operating as a standalone company under Alphabet.
History
On 9 September 2014, the division acquired Lift Labs, the makers of Liftware.{{cite web |url= https://www.forbes.com/sites/amitchowdhry/2014/09/10/google-acquires-tremor-canceling-device-company-lift-labs/ |title=Google Continues To Build Upon Its Life Sciences Ecosystem |first=Amit |last=Chowdhry |work=forbes.com |date=10 September 2014 |access-date=13 September 2014}}
Verily Life Sciences in January 2019 raised $1 billion in funding.
At the end of 2019, Verily sold its stake in robot-assisted surgery joint venture Verb Surgical to development partner Johnson & Johnson.{{cite web|url=https://www.fiercebiotech.com/medtech/j-j-to-take-over-verb-surgical-its-robotics-venture-verily |title=Johnson & Johnson to take over Verb Surgical, its robotics venture with Verily |last=Hale |first=Conor |date=December 20, 2019 |access-date=January 7, 2020 |website=FierceBiotech.com |archive-url=https://web.archive.org/web/20200108044643/https://www.fiercebiotech.com/medtech/j-j-to-take-over-verb-surgical-its-robotics-venture-verily |archive-date=January 8, 2020 |url-status=live}}
In August 2020, Verily announced that it is entering into the insurance market with the launch of Coefficient Insurance Company. The new subsidiary will be backed by Swiss Re Group's commercial insurance unit.{{Cite web|last=Peters|first=Jay|date=2020-08-25|title=Verily, Google's health-focused sister company, is getting into insurance|url=https://www.theverge.com/2020/8/25/21401124/alphabet-verily-insurance-coefficient-stop-loss|access-date=2020-09-16|website=The Verge|language=en}}
In September 2022, Verily announced longtime CEO Andy Conrad would step down as CEO in January 2023, to be replaced by Stephen Gillett{{Cite web |last=Alba, Love |date=9 September 2022 |title=Alphabet's Verily Raises $1 Billion and Shakes Up Leadership Team |website=Bloomberg News |url=https://www.bloomberg.com/news/articles/2022-09-09/verily-raises-1-billion-led-by-alphabet-shuffles-management}} who became CEO on January 3, 2023.{{Cite web |last=Scott |date=12 January 2023 |title=New Verily Life Sciences CEO to Cut 15% of Staff, Shake Up C-Suite |url=https://www.biospace.com/article/new-verily-life-sciences-ceo-to-cut-15-percent-of-staff-shake-up-c-suite/}}
In January 2023, fifteen percent of Verily's workforce was laid off as part of a broader restructuring by parent company, Alphabet.{{Cite news |last1=Weise |first1=Karen |last2=Grant |first2=Nico |last3=Isaac |first3=Mike |date=2023-03-08 |title=The Perils of Working on a C.E.O.'s Pet Project |language=en-US |work=The New York Times |url=https://www.nytimes.com/2023/03/08/technology/tech-big-bets-layoffs.html |access-date=2023-03-13 |issn=0362-4331}} The Information reported in August that Gillett had told employees they would stop relying on Alphabet on "a wide range of corporate services", signaling a potential spin-out as an independent company.{{Cite web |last=Victor |first=Jon |date=August 17, 2023 |title=Alphabet's Verily Moves Toward Spinoff as Revenue Surges |url=https://www.theinformation.com/articles/alphabets-verily-moves-toward-spinoff-as-revenue-surges |url-access=subscription |url-status=live |archive-url=https://web.archive.org/web/20230817162858/https://www.theinformation.com/articles/alphabets-verily-moves-toward-spinoff-as-revenue-surges |archive-date=August 17, 2023 |access-date=August 21, 2023 |website=The Information}}
In June 2024, Verily decided to close its operations in Israel three years after opening a research and development center in the country. Verily staff in Israel are expected to leave by the third quarter of 2024. The company cited an effort to refocus its strategy on core products and projects as the reason for the closure.{{Cite news |last=Robins-Early |first=Nick |date=2024-06-28 |title=Google’s biotech company pulls out of Israel but says Gaza war not the reason |url=https://www.theguardian.com/technology/article/2024/jun/28/google-verily-leave-israel |access-date=2024-06-29 |work=The Guardian |language=en-GB |issn=0261-3077}}
In August 2024, Verily moved its headquarters from South San Francisco to Dallas citing significant investment and involvement in the Texas healthcare and technology sectors.{{Cite news |title=Another Bay Area tech company plans to move headquarters to Texas |url=https://www.sfchronicle.com/health/article/verily-moves-corporate-hq-texas-19599393.php |work=The San Francisco Chronicle}}
Projects
- The Dexcom G7 continuous glucose monitors (CGM), developed in partnership with Dexcom, was FDA approved and launched worldwide in 2022.{{Cite web |title=Verily Life Sciences |url=https://verily.com/blog/one-of-the-smallest-most-discreet-continuous-glucose-monitoring-cgm-systems-receives-fda-clearance/ |access-date=2017-02-15 |website=verily.com}}{{Cite web |title=Dexcom G7 CGM - Powerfully simple diabetes management |url=https://www.dexcom.com/en-us/g7-cgm-system |access-date=2023-06-28 |website=Dexcom |language=en-US}}
- Galvani Bioelectronics, treating chronic conditions, including Rheumatoid Arthritis (RA), through targeted neuromodulation therapies, a joint venture with GlaxoSmithKline{{Cite web |title=Verily Life Sciences |url=https://verily.com/blog/galvani-bioelectronics-reaches-major-milestone-in-ra-neuromodulation-therapy-with-first-patient-implantation/ |access-date=2017-02-15 |website=verily.com}}
- Verb Surgical, for advancements in surgical robotics, a joint venture with Johnson & Johnson.{{cite web |last=Ackerman |first=Evan |date=3 March 2016 |title=Google and Johnson & Johnson Conjugate to Create Verb Surgical, Promise Fancy Medical Robots |url=https://spectrum.ieee.org/google-verily-johnson-johnson-verb-surgical-medical-robots |access-date=3 March 2016 |work=IEEE Spectrum}}
- A spoon for people with tremors as part of Lift Labs acquisition.{{cite web|url=https://www.theguardian.com/technology/2014/nov/25/google-launches-smart-spoon-shaking-hands-liftware|title=Google launches 'smart' spoon to help steady shaking hands|last=Rushe|first=Dominic|date=2014-11-25|work=The Guardian|access-date=25 November 2014}}{{Cite web |title=Liftware Steady {{!}} Liftware |url=https://www.liftware.com/steady/ |access-date=2023-06-28 |website=www.liftware.com}}
- The Baseline Study, a project to collect genetic, molecular, and wearable device information from enough people to create a picture of what a healthy human should be.{{cite web |url= https://www.science.org/content/article/google-x-sets-out-define-healthy-human |title=Google X sets out to define healthy human | Science/AAAS | News |first=Jocelyn |last=Kaiser |work=news.sciencemag.org |date=28 July 2014 |access-date=13 September 2014}}
- Onduo, a chronic disease management platform for patient with Diabetes, developed in partnership with Sanofi.{{Cite web|url=http://www.news.sanofi.us/2016-09-12-Sanofi-and-Verily-Life-Sciences-Announce-Launch-of-Onduo-a-Joint-Venture-to-Develop-Comprehensive-Diabetes-Management-Platform|title=Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform - Sep 12, 2016|website=news.sanofi.us|language=en|access-date=2018-08-16}}
- Study Watch, a health-tracking watch for clinical trials.{{Cite web |title=Verily Life Sciences |url=https://verily.com/blog/study-watch-another-step-closer-to-powering-precision-health/ |access-date=2023-03-08 |website=verily.com}}
= Discontinued =
- Contact lenses that allow people with diabetes to continually check their glucose levels using a non-intrusive method.{{cite web |author1=Brian Otis |author2=Babak Parviz |date=2014-01-16 |title=Introducing our smart contact lens project |url=http://googleblog.blogspot.com/2014/01/introducing-our-smart-contact-lens.html |access-date=2014-01-17 |work=Google}} On November 16, 2018, Verily announced it discontinued this project.{{cite web |author=Brian Otis |date=16 November 2018 |title=Update on our Smart Lens program with Alcon |url=https://blog.verily.com/2018/11/update-on-our-smart-lens-program-with.html |access-date=21 November 2018 |publisher=Verily Blog}}
- Smart shoes for health tracking and fall detection{{Cite news|url=https://9to5google.com/2019/02/01/verily-smart-shoes-health-tracking/|title=Verily developing smart shoes for health and weight tracking, fall detection|last=Li|first=Abner|date=1 February 2019|work=9to5Google|access-date=1 February 2019}}
- Skin research with L’Oréal{{Cite web|date=2022-01-20|title=Verily and L'Oréal team up on skin research and new digital tools|url=https://www.mobihealthnews.com/news/verily-and-l-or-al-team-skin-research-new-digital-tools|access-date=2022-01-30|website=MobiHealthNews|language=en}}
- A disease-detecting nanoparticle platform{{cite news|last1=Gibbs|first1=Samuel|title=Google is developing a cancer and heart attack-detecting pill|url=https://www.theguardian.com/technology/2014/oct/29/google-cancer-heart-attack-detecting-pill|access-date=20 January 2015|newspaper=The Guardian|date=29 October 2014}} working with the wristband, a project called Tricorder.{{cite news|url=https://www.statnews.com/2016/06/06/google-star-trek-fiction/|title='Silicon Valley arrogance'? Google misfires as it strives to turn Star Trek technology into reality|date=6 June 2016}}
See also
References
{{reflist|25em}}
{{Contract research organization|state=collapsed}}
{{Alphabet Inc.}}
Category:Alphabet Inc. subsidiaries
Category:American medical research
Category:Biotechnology companies of the United States
Category:Life sciences industry
Category:Science and technology in the San Francisco Bay Area
Category:Transhumanist organizations
Category:Companies based in South San Francisco, California